Clinical Trials List
Protocol NumberCLS2702-ESO-TW02
Not yet recruiting
2020-08-01 - 2023-12-31
Phase III
Terminated2
ICD-10C15.3
Malignant neoplasm of upper third of esophagus
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9150.3
Malignant neoplasm of upper third of esophagus
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/08/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
0 participants
